Cargando…

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients

BACKGROUND: CRIM1 is involved in the development and preservation of the nervous system, capillary development, and vascular maintenance. Although CRIM1 was reported to involve in multiple cancers, its role in breast cancer is unclear. METHODS: We investigated CRIM1 expression levels using Oncomine,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Wei, Jiang, Baohong, Cao, Xi, Xie, Liming, Zhang, Xiaoli, Li, Yuehua, He, Rongfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120825/ https://www.ncbi.nlm.nih.gov/pubmed/35600360 http://dx.doi.org/10.3389/fonc.2022.882328

Ejemplares similares

The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer
por: Tang, Liting, et al.
Publicado: (2021)

Un crim : i altres contes /
por: Calders, Pere, 1912-
Publicado: (1995)

Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer
por: Jiang, Baohong, et al.
Publicado: (2022)

circIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression
por: Li, Yuehua, et al.
Publicado: (2020)

Crim1 suppresses left ventricular hypertrophy
por: Yang, Long, et al.
Publicado: (2019)

Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer
por: Gao, Song, et al.
Publicado: (2021)

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer
por: Qi, Xiaowen, et al.
Publicado: (2022)

CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis
por: Du, Yuping, et al.
Publicado: (2021)

Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
por: Tang, Shasha, et al.
Publicado: (2023)

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer
por: Zhang, Yong-Qu, et al.
Publicado: (2021)

Crim1 regulates integrin signaling in murine lens development
por: Zhang, Ying, et al.
Publicado: (2016)

Essential Role of CRIM1 on Endometrial Receptivity in Goat
por: Yang, Diqi, et al.
Publicado: (2021)

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy
por: Zhang, Huikun, et al.
Publicado: (2021)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

High Moesin Expression Is a Predictor of Poor Prognosis of Breast Cancer: Evidence From a Systematic Review With Meta-Analysis
por: Hu, Xiaoli, et al.
Publicado: (2021)

High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer
por: Wu, Jialing, et al.
Publicado: (2021)

Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer
por: Xue, Jingyan, et al.
Publicado: (2021)

High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data
por: Liu, Weidong, et al.
Publicado: (2020)

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019)

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
por: Jiao, Ruidi, et al.
Publicado: (2020)

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL
por: Wang, Lu-Lu, et al.
Publicado: (2021)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

A novel CRT‐IMRT‐combined (Co‐CRIM) planning technique for peripheral lung stereotactic body radiotherapy in pinnacle treatment planning system
por: Duan, YanHua, et al.
Publicado: (2021)

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
por: Bali, Deeksha S., et al.
Publicado: (2015)

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma
por: Tamura, Akihiro, et al.
Publicado: (2020)

Low Pretreatment Albumin-to-Globulin Ratio Predicts Poor Prognosis in Gastric Cancer: Insight From a Meta-Analysis
por: Wei, Chengzhi, et al.
Publicado: (2021)

DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour
por: Mi, Tao, et al.
Publicado: (2022)

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer
por: Zhang, Ying, et al.
Publicado: (2021)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

Crim1 inhibits angiotensin II-induced hypertrophy and preserves Kv4.2 expression in cardiomyocytes
por: He, Jionghong, et al.
Publicado: (2022)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma
por: He, Miao, et al.
Publicado: (2023)

Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma
por: Wei, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tq22c1n51ndq5cd164s930j9ic